Association of low RKIP expression with poor prognosis in non-small cell lung cancer.

被引：1
|
作者：
Meng, Lingbin
Ji, Rui
Laber, Damian A.
Yan, Xuebo
Xu, Xiaochun
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Anhui Med Univ, Affiliated Hosp 1, Hefei, Anhui, Peoples R China
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.3068
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3068
引用
收藏
页数：2
相关论文
共 50 条
  • [1] MCAM expression is associated with poor prognosis in non-small cell lung cancer
    X. Zhang
    Z. Wang
    Y. Kang
    X. Li
    X. Ma
    L. Ma
    [J]. Clinical and Translational Oncology, 2014, 16 : 178 - 183
  • [2] MCAM expression is associated with poor prognosis in non-small cell lung cancer
    Zhang, X.
    Wang, Z.
    Kang, Y.
    Li, X.
    Ma, X.
    Ma, L.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (02): : 178 - 183
  • [3] The low advanced lung cancer inflammation index to predict poor prognosis of patients with metastatic non-small cell lung cancer.
    Lu, Ping
    Ma, Yifei
    Kai, Jindan
    Wang, Jun
    Yin, Zhucheng
    Xu, Hongli
    Li, Xinying
    Liang, Xin
    Wei, Shaozhong
    Liang, Xinjun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Low expression of FZD1 correlates with poor prognosis in non-small cell lung cancer
    Su, Wenmei
    Ye, Haiyin
    Wu, Fenping
    Mo, Yanli
    Li, Shujun
    Mai, Zongjiong
    Guo, Kangwen
    Li, Lixia
    Wang, Dong
    Yang, Zhixiong
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (08): : 8335 - 8342
  • [5] EXPRESSION OF TRKB AND BDNF IS ASSOCIATED WITH POOR PROGNOSIS IN NON-SMALL CELL LUNG CANCER
    Okamura, Kyoko
    Harada, Taishi
    Wang, Shuo
    Furuyama, Kazuto
    Ijichi, Kayo
    Koga, Takaomi
    Okamoto, Tatsuro
    Takayama, Koichi
    Yano, Tokujiro
    Nakanishi, Yoichi
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S471 - S471
  • [6] Expression of TrkB and BDNF is associated with poor prognosis in non-small cell lung cancer
    Okamura, Kyoko
    Harada, Taishi
    Wang, Shuo
    Ijichi, Kayo
    Furuyama, Kazuto
    Koga, Takaomi
    Okamoto, Tatsuro
    Takayama, Koichi
    Yano, Tokujiro
    Nakanishi, Yoichi
    [J]. LUNG CANCER, 2012, 78 (01) : 100 - 106
  • [7] Association of tumor-specific GPR87 overexpression with poor prognosis in non-small cell lung cancer.
    Nii, Kazuhito
    Liu, Dage
    Tokunaga, Yoshimasa
    Zhang, Xia
    Ishikawa, Shinya
    Haba, Reiji
    Kakehi, Yoshiyuki
    Yokomise, Hiroyasu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Loss of Bad expression confers poor prognosis in non-small cell lung cancer
    Yi Huang
    Dan Liu
    Bojiang Chen
    Jing Zeng
    Lei Wang
    Shangfu Zhang
    Xianming Mo
    Weimin Li
    [J]. Medical Oncology, 2012, 29 : 1648 - 1655
  • [9] High Expression of PHGDH Predicts Poor Prognosis in Non-Small Cell Lung Cancer
    Zhu, Jinhong
    Ma, Jianqun
    Wang, Xudong
    Ma, Tianjiao
    Zhang, Shu
    Wang, Wei
    Zhou, Xiaoyu
    Shi, Jiahai
    [J]. TRANSLATIONAL ONCOLOGY, 2016, 9 (06): : 592 - 599
  • [10] High expression of MYEOV reflects poor prognosis in non-small cell lung cancer
    Zhang, Rui
    Ma, Aiqing
    [J]. GENE, 2021, 770
12345